Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00949
Species: Homo sapiens
Position : chr8:129188417-129189959
Year: 2016
Title: Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: lung adenocarcinoma
PMID:  26656844
MONDO: MONDO:0005061
Tissue: lung
Tissue Ontology ID: UBERON:0002048
Cell Source: A-549
CVCL ID: CVCL_0023
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; TF binding assay; TF motif functional assay; Endogenous enhancer perturbation
High Throughput Method: H3K27ac ChIP-seq; p300 ChIP-seq; DNase-seq; CEBPB ChIP-seq
Low Throughput Method: Luciferase reporter assay; mini-e3 reporter dissection; site-directed CEBPB motif deletion; CEBPB siRNA knockdown; RT-qPCR; Western blot; CRISPR-Cas9 endogenous deletion/editing
About Target Gene
Target gene : MYC
About TF
TF name : CEBPB
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
CEBPB C-MYB transcription factor network pid 87
CEBPB EGFR1 netpath 475
CEBPB FOXA1 transcription factor network pid 45
CEBPB FOXA2 and FOXA3 transcription factor networks pid 45
CEBPB IFN-gamma pathway pid 43
CEBPB IL3-mediated signaling events pid 27
CEBPB IL4-mediated signaling events pid 66
CEBPB IL4 netpath 75
CEBPB IL6-mediated signaling events pid 48
CEBPB IL6 netpath 85
CEBPB RANKL netpath 84
CEBPB Regulation of nuclear SMAD2/3 signaling pid 82
CEBPB Regulation of retinoblastoma protein pid 67
CEBPB Senescence-Associated Secretory Phenotype (SASP) reactome 108
CEBPB Signaling mediated by p38-alpha and p38-beta pid 35
CEBPB TCR netpath 261
CEBPB Transcriptional regulation of white adipocyte differentiation reactome 79
CEBPB Validated nuclear estrogen receptor alpha network pid 65
CEBPB Hs_Senescence_and_Autophagy_in_Cancer_WP615_81193 wikipathways 62
CEBPB Hs_Oncostatin_M_Signaling_Pathway_WP2374_73668 wikipathways 44
CEBPB Hs_Transcriptional_activation_by_NRF2_WP3_79527 wikipathways 6
CEBPB Hs_Lung_fibrosis_WP3624_91475 wikipathways 23
CEBPB Hs_IL17_signaling_pathway_WP2112_89838 wikipathways 20
Enhancer Associated Network
Overlapping Enhancers (hg19) 9 found
Enhancer ID Position Tissue Cell Disease
E_00951 chr8:129166547-129190290 lung malignant cell lung adenocarcinoma
E_00974 chr8:129166547-129190290 lung malignant cell lung adenocarcinoma
E_00975 chr8:129166547-129190290 lung malignant cell lung adenocarcinoma
E_02502 chr8:129180000-129190000 lymph node B cell diffuse large B-cell lymphoma
E_02503 chr8:129180000-129190000 lymph node B cell diffuse large B-cell lymphoma
E_02504 chr8:129180000-129190000 lymph node B cell diffuse large B-cell lymphoma
E_00950 chr8:129188417-129189959 lung malignant cell lung adenocarcinoma
E_01020 chr8:129188417-129189959 lymph node malignant cell lung adenocarcinoma
E_01025 chr8:129188417-129189959 lung club cell lung adenocarcinoma
Expression of Target Genes for the Enhancer